Skip to main content

Mitral Valve Insufficiency clinical trials at UC Health
2 in progress, 1 open to new patients

  • MitrAl ValvE RepaIr Clinical Trial (MAVERIC Trial) - United States

    open to eligible people ages 21-85

    The objective of the study is to evaluate the safety and feasibility of the ARTO System in patients with mitral valve regurgitation (MR) associated with congestive heart failure (CHF).

    at UC Davis

  • Real World Expanded Multicenter Study of the MitraClip® System (REALISM)

    Sorry, in progress, not accepting new patients

    Prospective, multicenter, continued access registry of the MitraClip® Cardiovascular Valve Repair System in the treatment of mitral valve regurgitation. Patients will undergo 30-day, 6-month, 12-month, 36-month and 60-month clinical follow-up. The study consists of two arms: a High Risk group (NCT01940120) and a Non-High Risk group (NCT00209274) . Patients that did not meet REALISM High Risk or Non-High Risk eligibility criteria were evaluated for consideration for either Emergency Use (EU) or Compassionate Use (CU).

    at UC Davis

Last updated: